NCT02296242 · Interventional trial
Phase 1/2 Study of the ERK1/2 Inhibitor BVD-523 in Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndromes
Overall registry status Completed
Phase 1 · Phase 2
Conditions Acute Myelogenous Leukemia, Myelodysplastic Syndrome
Delaware Valley sites
- Perelman Center for Advanced Medicine · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory